文献速递细菌感染、耐药与抗菌药物医院感染防控

强化筛查项目对碳青霉烯酶肠杆菌目细菌检出率的影响评估

Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该研究评估了伦敦多院区医院集团于2015年6月推出的强化碳青霉烯酶肠杆菌目细菌(CPE)感染防控与筛查项目。

要点

  • 强化筛查使CPE检出患者数增加,但筛查阳性率稳定在约0.4%,提示定植率未变而载体识别增加。
  • 临床培养CPE检出率无显著变化(P=0.07),未反映临床感染负担增加。
  • 扩大筛查可发现既往未识别的CPE定植储库,但需结合临床培养监测评估感染风险。

核心结论

  • 强化筛查项目识别了既往未检测到的CPE定植储库,但临床培养CPE检出率未增加。

研究设计与样本

  • 单中心多院区前后对照研究,纳入2014年4月至2018年3月所有非重复CPE分离株,评估2015年6月推出的强化筛查政策。

主要发现

  • CPE检出患者从2015年7月的18例(1.0/1000入院)增至2018年3月的50例(2.7/1000入院)。
  • 筛查培养CPE阳性比例全程维持在约0.4%。
  • 研究期间经临床培养阳性识别123例患者,临床培养CPE每1000入院检出率无显著变化(P=0.07)。

临床怎么用

  • 强化入院筛查、接触追踪和环境消毒可提高CPE定植识别,但需监测临床培养检出率以评估感染控制效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The transmission of carbapenemase-producing Enterobacterales (CPE) poses an increasing healthcare challenge. A range of infection prevention activities, including screening and contact precautions, are recommended by international and national guidelines. We evaluated the introduction of an enhanced screening programme in a multisite London hospital group. METHODS: In June 2015, an enhanced CPE policy was launched in response to a local rise in CPE detection. This increased infection prevention measures beyond the national recommendations, with enhanced admission screening, contact tracing and environmental disinfection, improved laboratory protocols and staff/patient education. We report the CPE incidence and trends of CPE in screening and clinical cultures and the adoption of enhanced CPE screening. All non-duplicate CPE isolates identified between April 2014 and March 2018 were included. RESULTS: The number of CPE screens increased progressively, from 4530 in July 2015 to 10 589 in March 2018. CPE detection increased from 18 patients in July 2015 (1.0 per 1000 admissions) to 50 patients in March 2018 (2.7 per 1000 admissions). The proportion of CPE-positive screening cultures remained at approximately 0.4% throughout, suggesting that whilst the CPE carriage rate was unchanged, carrier identification increased. Also, 123 patients were identified through positive CPE clinical cultures over the study period; there was no significant change in the rate of CPE from clinical cultures per 1000 admissions (P = 0.07). CONCLUSIONS: Our findings suggest that whilst the enhanced screening programme identified a previously undetected reservoir of CPE colonization in our patient population, the rate of detection of CPE in clinical cultures did not increase.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Otter JA, Mookerjee S, Davies F, et al. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care. J Antimicrob Chemother. 2020. PMID: 32479615. doi:10.1093/jac/dkaa192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。